CN Stock MarketDetailed Quotes

Hinova Pharmaceuticals Inc. (688302)

Watchlist
  • 43.83
  • +0.28+0.64%
Market Closed May 19 15:00 CST
4.34BMarket Cap-32.13P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hinova Pharmaceuticals Inc. (688302) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Drugs20.19M98.65%
医药中间体等277.34K1.35%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry20.47M100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory20.47M99.98%
Overseas3.73K0.02%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.54%
Sample Name
Sample Code
 +4.71%
Sample Name
Sample Code
 0.00%
4
SHANGHAI PECHEM
00338
-0.81%
5
SINOPEC CORP
00386
-0.88%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +42.01%
Sample Name
Sample Code
 +32.82%
Sample Name
Sample Code
 +26.86%
4
Emdoor Information
001314
+25.83%
5
Digital China Group
000034
+20.88%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 19 Eastern Time, Trump warned that Iran might only have a negotiating window until Sunday or early next week, adding that 'it may be Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -